01 October 2013 9,134 Be the first to comment
This content has been created by the Finextra editorial team with inputs from subject matter experts at the funding sponsor.
Mike Foley, MD at Peterevans, discusses the recent increase M&As and other corporate actions.
Welcome to Finextra. We use cookies to help us to deliver our services. You may change your preferences at our Cookie Centre.
Please read our Privacy Policy.